|
[1]
|
Kratz, C.P. (2025) Re-Envisioning Genetic Predisposition to Childhood and Adolescent Cancers. Nature Reviews Cancer, 25, 109-128. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Shevach, J.W., Xu, J., Snyder, N., Wei, J., Shi, Z., Tran, H., et al. (2025) Established Cancer Predisposition Genes in Single and Multiple Cancer Diagnoses. JAMA Oncology, 11, 1222-1230. [Google Scholar] [CrossRef]
|
|
[3]
|
Liu, Y.L., Cadoo, K.A., Mukherjee, S., Khurram, A., Tkachuk, K., Kemel, Y., et al. (2022) Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations. Cancer Epidemiology, Biomarkers & Prevention, 31, 362-371. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Breast Cancer Association Consortium (2021) Breast Cancer Risk Genes—Association Analysis in More than 113,000 Women. New England Journal of Medicine, 384, 428-439. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hu, C., Hart, S.N., Gnanaolivu, R., Huang, H., Lee, K.Y., Na, J., et al. (2021) A Population-Based Study of Genes Previously Implicated in Breast Cancer. New England Journal of Medicine, 384, 440-451. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Dominguez-Valentin, M., Sampson, J.R., Seppälä, T.T., ten Broeke, S.W., Plazzer, J., Nakken, S., et al. (2020) Cancer Risks by Gene, Age, and Gender in 6350 Carriers of Pathogenic Mismatch Repair Variants: Findings from the Prospective Lynch Syndrome Database. Genetics in Medicine, 22, 15-25. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Fummey, E., Navarro, P., Plazzer, J., Frayling, I.M., Knott, S. and Tenesa, A. (2024) Estimating Cancer Risk in Carriers of Lynch Syndrome Variants in UK Biobank. Journal of Medical Genetics, 61, 861-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Werf-’t Lam, A.v.d., Dowty, J.G., Italia, M., Bakker, A.C., Koops, F., Bleeker, F., et al. (2025) Cancer Risks for MSH6 Pathogenic Variant Carriers. European Journal of Cancer, 231, Article ID: 116098. [Google Scholar] [CrossRef]
|
|
[9]
|
Galante, P.A.F., Guardia, G.D.A., Pisani, J., Sandoval, R.L., Barros-Filho, M.C., Gifoni, A.C.L.V.C., et al. (2025) Personalized Screening Strategies for TP53 R337H Carriers: A Retrospective Cohort Study of Tumor Spectrum in Li-Fraumeni Syndrome Adult Carriers. The Lancet Regional Health—Americas, 42, Article ID: 100982. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Finn, E., Sardo Infirri, S., Clarke, C.S., Bunce, C., Weng, J.Y., Lee, R.W., et al. (2025) Li Fraumeni Syndrome in the UK: Clinical Characteristics and Outcomes of TP53 Carriers. ESMO Open, 10, Article ID: 105541. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., et al. (1991) Identification and Characterization of the Familial Adenomatous Polyposis Coli Gene. Cell, 66, 589-600. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., et al. (1991) Mutations of Chromosome 5q21 Genes in FAP and Colorectal Cancer Patients. Science, 253, 665-669. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., et al. (2018) Genetic and Transcriptional Evolution Alters Cancer Cell Line Drug Response. Nature, 560, 325-330. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., et al. (2018) Patient-Derived Organoids Model Treatment Response of Metastatic Gastrointestinal Cancers. Science, 359, 920-926. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S., et al. (2012) The Cancer Cell Line Encyclopedia Enables Predictive Modelling of Anticancer Drug Sensitivity. Nature, 483, 603-607. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Yao, Y., Xu, X., Yang, L., Zhu, J., Wan, J., Shen, L., et al. (2020) Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer. Cell Stem Cell, 26, 17-26.e6. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Ganesh, K., Wu, C., O’Rourke, K.P., Szeglin, B.C., Zheng, Y., Sauvé, C.G., et al. (2019) A Rectal Cancer Organoid Platform to Study Individual Responses to Chemoradiation. Nature Medicine, 25, 1607-1614. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Kopper, O., de Witte, C.J., Lõhmussaar, K., Valle-Inclan, J.E., Hami, N., Kester, L., et al. (2019) An Organoid Platform for Ovarian Cancer Captures Intra-and Interpatient Heterogeneity. Nature Medicine, 25, 838-849. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell, 131, 861-872. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wang, M., Zhang, Y., Bi, C. and Li, M. (2025) CRISPR-Cas9-Induced Double-Strand Breaks Disrupt Maintenance of Epigenetic Information. Genome Biology, 26, Article No. 411. [Google Scholar] [CrossRef]
|
|
[21]
|
Anzalone, A.V., Randolph, P.B., Davis, J.R., Sousa, A.A., Koblan, L.W., Levy, J.M., et al. (2019) Search-and-Replace Genome Editing without Double-Strand Breaks or Donor DNA. Nature, 576, 149-157. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Yucer, N., Ahdoot, R., Workman, M.J., Laperle, A.H., Recouvreux, M.S., Kurowski, K., et al. (2021) Human iPSC-Derived Fallopian Tube Organoids with BRCA1 Mutation Recapitulate Early-Stage Carcinogenesis. Cell Reports, 37, Article ID: 110146. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Heinzelmann, E., Piraino, F., Costa, M., Roch, A., Norkin, M., Garnier, V., et al. (2024) iPSC-Derived and Patient-Derived Organoids: Applications and Challenges in Scalability and Reproducibility as Pre-Clinical Models. Current Research in Toxicology, 7, Article ID: 100197. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Edahiro, R., Sato, G., Naito, T., Shirai, Y., Saiki, R., Sonehara, K., et al. (2025) Deciphering State-Dependent Immune Features from Multi-Layer Omics Data at Single-Cell Resolution. Nature Genetics, 57, 1905-1921. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Papier, K., Atkins, J.R., Tong, T.Y.N., Gaitskell, K., Desai, T., Ogamba, C.F., et al. (2024) Identifying Proteomic Risk Factors for Cancer Using Prospective and Exome Analyses of 1463 Circulating Proteins and Risk of 19 Cancers in the UK Biobank. Nature Communications, 15, Article No. 4010. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., et al. (2010) Cell Type of Origin Influences the Molecular and Functional Properties of Mouse Induced Pluripotent Stem Cells. Nature Biotechnology, 28, 848-855. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lee, D., Su, J., Kim, H.S., Chang, B., Papatsenko, D., Zhao, R., et al. (2015) Modeling Familial Cancer with Induced Pluripotent Stem Cells. Cell, 161, 240-254. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Reed, A.D., Pensa, S., Steif, A., Stenning, J., Kunz, D.J., Porter, L.J., et al. (2024) A Single-Cell Atlas Enables Mapping of Homeostatic Cellular Shifts in the Adult Human Breast. Nature Genetics, 56, 652-662. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Bohaumilitzky, L., Kluck, K., Hüneburg, R., Gallon, R., Nattermann, J., Kirchner, M., et al. (2022) The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients. Gastroenterology, 162, 907-919.e10. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Burridge, P.W., Li, Y.F., Matsa, E., Wu, H., Ong, S., Sharma, A., et al. (2016) Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Recapitulate the Predilection of Breast Cancer Patients to Doxorubicin-Induced Cardiotoxicity. Nature Medicine, 22, 547-556. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Novoa Díaz, M.B., Carriere, P., Gigola, G., Zwenger, A.O., Calvo, N. and Gentili, C. (2022) Involvement of Met Receptor Pathway in Aggressive Behavior of Colorectal Cancer Cells Induced by Parathyroid Hormone-Related Peptide. World Journal of Gastroenterology, 28, 3177-3200. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Tabe, S., Takeuchi, K., Aoshima, K., Okumura, A., Yamamoto, Y., Yanagisawa, K., et al. (2025) A Pancreatic Cancer Organoid Incorporating Macrophages Reveals the Correlation between the Diversity of Tumor-Associated Macrophages and Cancer Cell Survival. Biomaterials, 314, Article ID: 122838. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Ghobadi, A., Bachanova, V., Patel, K., Park, J.H., Flinn, I., Riedell, P.A., et al. (2025) Induced Pluripotent Stem-Cell-Derived CD19-Directed Chimeric Antigen Receptor Natural Killer Cells in B-Cell Lymphoma: A Phase 1, First-In-Human Trial. The Lancet, 405, 127-136. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Zhu, H., Blum, R.H., Bernareggi, D., Ask, E.H., Wu, Z., Hoel, H.J., et al. (2020) Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes in Vivo Persistence and Enhances Anti-Tumor Activity. Cell Stem Cell, 27, 224-237.e6. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Ozgencil, M., Barwell, J., Tischkowitz, M., Izatt, L., Kesterton, I., Simpson, M., et al. (2021) Assessing BRCA1 Activity in DNA Damage Repair Using Human Induced Pluripotent Stem Cells as an Approach to Assist Classification of BRCA1 Variants of Uncertain Significance. PLOS ONE, 16, e0260852. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Li, Y., Wang, Y., Wang, W., Zhang, X., Shen, R., Jin, K., et al. (2022) Second Hit Impels Oncogenesis of Retinoblastoma in Patient-Induced Pluripotent Stem Cell-Derived Retinal Organoids: Direct Evidence for Knudson’s Theory. PNAS Nexus, 1, pgac162. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Haapaniemi, E., Botla, S., Persson, J., Schmierer, B. and Taipale, J. (2018) CRISPR-Cas9 Genome Editing Induces a P53-Mediated DNA Damage Response. Nature Medicine, 24, 927-930. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Ihry, R.J., Worringer, K.A., Salick, M.R., Frias, E., Ho, D., Theriault, K., et al. (2018) p53 Inhibits CRISPR-Cas9 Engineering in Human Pluripotent Stem Cells. Nature Medicine, 24, 939-946. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Kosicki, M., Tomberg, K. and Bradley, A. (2018) Repair of Double-Strand Breaks Induced by CRISPR-Cas9 Leads to Large Deletions and Complex Rearrangements. Nature Biotechnology, 36, 765-771. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Tiriac, H., Belleau, P., Engle, D.D., Plenker, D., Deschênes, A., Somerville, T.D.D., et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discovery, 8, 1112-1129. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Liu, J., Zhao, C., Chen, J., Zeng, P., Li, Q., Dai, R., et al. (2025) Human iPSC-Based Breast Cancer Model Identifies S100P-Dependent Cancer Stemness Induced by brca1 Mutation. Science Advances, 11, eadi2370. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Sommer, C.A., Capilla, A., Molina-Estevez, F.J., Gianotti-Sommer, A., Skvir, N., Caballero, I., et al. (2018) Modeling APC Mutagenesis and Familial Adenomatous Polyposis Using Human iPS Cells. PLOS ONE, 13, e0200657. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Soyombo, A.A., Wu, Y., Kolski, L., Rios, J.J., Rakheja, D., Chen, A., et al. (2013) Analysis of Induced Pluripotent Stem Cells from a BRCA1 Mutant Family. Stem Cell Reports, 1, 336-349. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Silva, T.P., Pereira, C.A., Oliveira, A.R., Raposo, A.C., Arez, M., Cabral, J.M.S., et al. (2021) Generation and Characterization of Induced Pluripotent Stem Cells from a Family Carrying the BRCA1 Mutation c.3612delA. Stem Cell Research, 52, Article ID: 102242. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Weddle, C.J., Blancard, M., Uche, N., Pongpamorn, P., Cejas, R.B. and Burridge, P.W. (2025) Examining Patient-Specific Responses to PARP Inhibitors in a Novel, Human Induced Pluripotent Stem Cell-Based Model of Breast Cancer. NPJ Precision Oncology, 9, Article No. 53. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Portier, L., Desterke, C., Chaker, D., Oudrhiri, N., Asgarova, A., Dkhissi, F., et al. (2021) iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression. International Journal of Molecular Sciences, 22, Article No. 1227. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Chung, J., Maruvka, Y.E., Sudhaman, S., Kelly, J., Haradhvala, N.J., Bianchi, V., et al. (2021) DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. Cancer Discovery, 11, 1176-1191. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Sun, J., Ren, L., Canel Rivero, G., Xu, L., Ladabaum, U. and C. Wu, J. (2024) Generation of Two Induced Pluripotent Stem Cell Lines from Patients with Li-Fraumeni Syndrome Carrying TP53 Mutation. Stem Cell Research, 81, Article ID: 103527. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Steinbach, G., Lynch, P.M., Phillips, R.K.S., Wallace, M.H., Hawk, E., Gordon, G.B., et al. (2000) The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis. New England Journal of Medicine, 342, 1946-1952. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Phillips, R.K.S., Wallace, M.H., Lynch, P.M., Hawk, E., Gordon, G.B., Saunders, B.P., et al. (2002) A Randomised, Double Blind, Placebo Controlled Study of Celecoxib, a Selective Cyclooxygenase 2 Inhibitor, on Duodenal Polyposis in Familial Adenomatous Polyposis. Gut, 50, 857-860. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Lovell-Badge, R., Anthony, E., Barker, R.A., Bubela, T., Brivanlou, A.H., Carpenter, M., et al. (2021) ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 Update. Stem Cell Reports, 16, 1398-1408. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Taapken, S.M., Nisler, B.S., Newton, M.A., Sampsell-Barron, T.L., Leonhard, K.A., McIntire, E.M., et al. (2011) Karyotypic Abnormalities in Human Induced Pluripotent Stem Cells and Embryonic Stem Cells. Nature Biotechnology, 29, 313-314. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Finkbeiner, S.R., Hill, D.R., Altheim, C.H., Dedhia, P.H., Taylor, M.J., Tsai, Y., et al. (2015) Transcriptome-Wide Analysis Reveals Hallmarks of Human Intestine Development and Maturation in Vitro and in Vivo. Stem Cell Reports, 4, 1140-1155. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Miller, J.D., Ganat, Y.M., Kishinevsky, S., Bowman, R.L., Liu, B., Tu, E.Y., et al. (2013) Human Ipsc-Based Modeling of Late-Onset Disease via Progerin-Induced Aging. Cell Stem Cell, 13, 691-705. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Studer, L., Vera, E. and Cornacchia, D. (2015) Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. Cell Stem Cell, 16, 591-600. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Mertens, J., Paquola, A.C.M., Ku, M., Hatch, E., Böhnke, L., Ladjevardi, S., et al. (2015) Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. Cell Stem Cell, 17, 705-718. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Hu, J.L., Todhunter, M.E., LaBarge, M.A. and Gartner, Z.J. (2018) Opportunities for Organoids as New Models of Aging. Journal of Cell Biology, 217, 39-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Yasuda, S., Bando, K., Henry, M.P., Libertini, S., Watanabe, T., Bando, H., et al. (2024) Detection of Residual Pluripotent Stem Cells in Cell Therapy Products Utilizing Droplet Digital PCR: An International Multisite Evaluation Study. Stem Cells Translational Medicine, 13, 1001-1014. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Sinha, S., Barbosa, K., Cheng, K., Leiserson, M.D.M., Jain, P., Deshpande, A., et al. (2021) A Systematic Genome-Wide Mapping of Oncogenic Mutation Selection during CRISPR-Cas9 Genome Editing. Nature Communications, 12, Article No. 6512. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Lotfollahi, M., Naghipourfar, M., Luecken, M.D., Khajavi, M., Büttner, M., Wagenstetter, M., et al. (2022) Mapping Single-Cell Data to Reference Atlases by Transfer Learning. Nature Biotechnology, 40, 121-130. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Yang, D., Jones, M.G., Naranjo, S., Rideout, W.M., Min, K.H., et al. (2022) Lineage Tracing Reveals the Phylodynamics, Plasticity, and Paths of Tumor Evolution. Cell, 185, 1905-1923.e25. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Ashuach, T., Gabitto, M.I., Koodli, R.V., Saldi, G., Jordan, M.I. and Yosef, N. (2023) MultiVI: Deep Generative Model for the Integration of Multimodal Data. Nature Methods, 20, 1222-1231. [Google Scholar] [CrossRef] [PubMed]
|